Today: 21 May 2026
Browse Category

NYSE:BABA 10 February 2025 - 28 June 2025

Major Tech Developments in June 2025 and H2 2025 Outlook

Major Tech Developments in June 2025 and H2 2025 Outlook

Apple opened its on-device AI large language model to third-party developers at WWDC 2025. Nvidia reported Q1 fiscal 2026 revenue of $44.1 billion, up 69% year over year, and began full-scale Blackwell NVL72 chip production. Tesla deployed its first driverless robotaxi in Austin, Texas in June. OpenAI hit a $10 billion annual revenue run-rate and started using Google TPUs alongside Azure.
28 June 2025
·············
Quantum Computing Trends 2025: Major Breakthroughs, Key Players, and Global Insights

Quantum Computing Trends 2025: Major Breakthroughs, Key Players, and Global Insights

Researchers in 2025 unveiled the first topological quantum processor, an 8-qubit device using Majorana particles. D-Wave’s quantum annealer solved a magnetic simulation in minutes, far outpacing classical supercomputers. Google launched a 105-qubit superconducting chip with advanced error correction, while IBM surpassed 1,000 qubits with its Condor processor. The UN declared 2025 the International Year of Quantum Science and Technology.
27 June 2025
·······
Top 10 Web Browsers of 2025: Features, Security, Market Share & Performance Comparison

Top 10 Web Browsers of 2025: Features, Security, Market Share & Performance Comparison

Google Chrome controls about 66–67% of the global browser market in 2025. Safari holds 17–18%, while Microsoft Edge has 5% overall and 13.8% of desktop use. Firefox, Opera, Samsung Internet, Brave, Vivaldi, UC Browser, and Yandex each account for less than 3% globally. Yandex reaches 18% share in Russia.
19 June 2025
·······
Internet Access in China

Internet Access in China

China had 1.09 billion internet users by end-2023, with over 99% on mobile. State-owned ISPs—China Telecom, China Unicom, and China Mobile—control regional access and backbone networks. All international traffic passes through three government-run gateways, slowing foreign site access. The Great Firewall blocks major foreign platforms and censors content; VPN use is tightly restricted.
10 February 2025
···········
1 … 4 5 6

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop